Cargando…
Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study
Autores principales: | Hardy, Michael, Michaux, Isabelle, Dive, Alain, Lecompte, Thomas, Mullier, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116170/ https://www.ncbi.nlm.nih.gov/pubmed/34007953 http://dx.doi.org/10.1055/s-0041-1728722 |
Ejemplares similares
-
Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study
por: Hardy, M., et al.
Publicado: (2023) -
Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data
por: Hardy, Michaël, et al.
Publicado: (2020) -
Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
por: Godon, Alexandre, et al.
Publicado: (2021) -
Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
por: Lardinois, Benjamin, et al.
Publicado: (2022) -
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study
por: Hardy, Michaël, et al.
Publicado: (2021)